Last update 12 Sep 2026

DWP-708

Overview

Basic Info

Drug Type
Biological products
Synonyms
DWP 708, DWP-708
Target
EGFR
Action
agonists
Mechanism
EGFR agonists(Epidermal growth factor receptor erbB1 agonists)
Therapeutic Areas
Skin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Acneiform Eruptions
Originator Organization
Daewoong Pharmaceutical Co., Ltd.Daewoong Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
Daewoong Pharmaceutical Co., Ltd.Daewoong Pharmaceutical Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with DWP-708
NCT05378360
/ CompletedPhase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of DWP708
100 Clinical Results associated with DWP-708
Login to view more data
100 Translational Medicine associated with DWP-708
Login to view more data
100 Patents (Medical) associated with DWP-708
Login to view more data
100 Deals associated with DWP-708
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acneiform EruptionsPhase 2
South Korea
Daewoong Pharmaceutical Co., Ltd.Daewoong Pharmaceutical Co., Ltd.
02 May 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT05378360 (ESMO2025)
Phase 2
-
95
ckvdnpjvrw(egpbfjcrnq) = There were no significant differences in response rate assessed by an independent evaluator after 4 weeks of treatment. However, response rates were higher in all treatment groups than in the control group. The highest response rate was reported in patients treated with 20 μg/g of DWP708, with 50.0% of response rate. qrllwuzgto (jfjudzxcwg )
View more
Positive
17 Oct 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free